Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.64
Delayed Data
As of Jul 31
 +0.05 / +3.14%
Today’s Change
1.53
Today|||52-Week Range
3.45
-10.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues3.0M34.4M11.5M15.2M
 
 
 
 
 
Cost of Goods Sold1.3M4.5M1.9M5.9M
 
 
 
 
 
Depreciation And Amortization3.6M3.7M3.5M3.1M
 
 
 
 
 
 
Operating ExpensesGross Income-2.0M26.3M6.1M6.1M
 
 
 
 
 
General Expenses34.6M37.5M40.7M38.4M
 
 
 
 
 
Research And Development28.0M28.7M33.3M29.8M
 
 
 
 
 
Total Operating Expenses39.5M45.6M46.1M47.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.5M-11.2M-34.6M-32.3M
 
 
 
 
 
Extraordinary Charge-10.0K-1.0M-1.0M-1.0M
 
 
 
 
 
Interest Expense On Debt0.000.00674.0K4.9M
 
 
 
Other Expenses0.000.008.5M8.1M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.5M-11.6M-27.8M-29.9M
 
 
 
 
 
Net Income-36.5M-11.6M-27.8M-29.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS84.6M90.8M92.4M92.9M
 
 
 
 
 
Shares To Calculate EPS Diluted84.6M90.8M92.4M92.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.13-$0.30-$0.32
 
 
 
 
 
EPS Diluted-$0.43-$0.13-$0.30-$0.32